Newbridge Financial Services Group’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Hold |
0
| – | -$1 | – | 1158 |
|
|
2023
Q3 | – | Hold |
0
| – | -$4 | – | 1281 |
|
|
2023
Q2 | – | Hold |
0
| – | -$18 | – | 1344 |
|
|
2023
Q1 | – | Hold |
0
| – | -$50 | – | 1396 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 1416 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 1382 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 1362 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 1438 |
|
|
2021
Q4 | – | Hold |
0
| – | -$1K | – | 1414 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 1224 |
|
|
2021
Q2 | – | Hold |
0
| – | -$1K | – | 1432 |
|
|
2021
Q1 | – | Hold |
0
| – | -$1K | – | 1232 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 1005 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 1029 |
|